We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$110B
AUM Growth
+$13.5B
Cap. Flow
+$623M
Cap. Flow %
0.57%
Top 10 Hldgs %
19.69%
Holding
4,289
New
439
Increased
1,583
Reduced
1,749
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 11.42%
2 Financials 9.4%
3 Healthcare 9.26%
4 Consumer Discretionary 6.46%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBZ icon
2276
CBIZ
CBZ
$2.99B
$2.11M ﹤0.01%
104,087
+5,060
+5% +$102K
RPV icon
2277
Invesco S&P 500 Pure Value ETF
RPV
$1.67B
$2.11M ﹤0.01%
33,408
-150,599
-82% -$9.45M
MDCO
2278
DELISTED
Medicines Co
MDCO
$2.11M ﹤0.01%
75,377
+19,302
+34% +$455K
RWED
2279
DELISTED
Direxion MSCI Emerging Over Developed Markets ETF
RWED
$2.1M ﹤0.01%
+40,150
New +$2.09M
PDCO
2280
DELISTED
Patterson Companies, Inc.
PDCO
$2.1M ﹤0.01%
96,032
-21,942
-19% -$486K
FNHC
2281
DELISTED
FedNat Holding Company Common Stock
FNHC
$2.1M ﹤0.01%
+130,678
New +$2.37M
ATRI
2282
DELISTED
Atrion Corp
ATRI
$2.1M ﹤0.01%
2,385
+510
+27% +$402K
QTNA
2283
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
$2.09M ﹤0.01%
85,784
+66,520
+345% +$1.16M
RDC
2284
DELISTED
Rowan Companies Plc
RDC
$2.08M ﹤0.01%
193,020
+48,948
+34% +$570K
MTH icon
2285
Meritage Homes
MTH
$4.71B
$2.07M ﹤0.01%
92,530
-13,320
-13% -$285K
TELL
2286
DELISTED
Tellurian Inc.
TELL
$2.07M ﹤0.01%
184,498
-68,707
-27% -$646K
MD icon
2287
Pediatrix Medical
MD
$2.16B
$2.06M ﹤0.01%
75,965
-719,287
-90% -$24.1M
UHT
2288
Universal Health Realty Income Trust
UHT
$592M
$2.06M ﹤0.01%
27,181
-3,488
-11% -$248K
ENTA icon
2289
Enanta Pharmaceuticals
ENTA
$377M
$2.05M ﹤0.01%
21,435
-6,065
-22% -$544K
AIT icon
2290
Applied Industrial Technologies
AIT
$13B
$2.05M ﹤0.01%
34,406
-48,479
-58% -$2.81M
NVTA
2291
DELISTED
Invitae Corporation
NVTA
$2.04M ﹤0.01%
87,238
+60,674
+228% +$1.07M
DY icon
2292
Dycom Industries
DY
$12.5B
$2.04M ﹤0.01%
44,403
+7,793
+21% +$427K
PRLB icon
2293
Protolabs
PRLB
$1.92B
$2.04M ﹤0.01%
19,366
-3,975
-17% -$446K
AEL
2294
DELISTED
American Equity Investment Life Holding Company
AEL
$2.04M ﹤0.01%
75,368
+7,949
+12% +$241K
AVNS
2295
DELISTED
Avanos Medical
AVNS
$2.03M ﹤0.01%
47,634
-13,174
-22% -$590K
GPK icon
2296
Graphic Packaging
GPK
$3.36B
$2.03M ﹤0.01%
160,771
-41,216
-20% -$501K
PLXS icon
2297
Plexus
PLXS
$6.98B
$2.02M ﹤0.01%
33,090
+952
+3% +$55K
LPSN icon
2298
LivePerson
LPSN
$22.1M
$2.02M ﹤0.01%
4,634
+1,175
+34% +$440K
SPSC icon
2299
SPS Commerce
SPSC
$2.72B
$2.02M ﹤0.01%
38,030
-6,826
-15% -$334K
HNI icon
2300
HNI Corp
HNI
$3.43B
$2.02M ﹤0.01%
55,521
+6,483
+13% +$249K

Similar funds

Credit Suisse's Q1 2019 Portfolio in Review

As of Q1 2019, Credit Suisse held 4,289 positions worth $110B, up 14% from $96.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Credit Suisse's Q1 2019 filing shows 439 new, 1,583 increased, 1,749 reduced and 327 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 4,000,000 shares worth $232M. The largest sale was iShares MSCI Brazil ETF, an estimated $574M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Credit Suisse's largest Q1 2019 buy was iShares Core MSCI Total International Stock ETF: 4,000,000 shares worth $232M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $1.78B increase.
  • Credit Suisse's biggest Q1 2019 reduction was iShares MSCI Brazil ETF, cutting an estimated $574M.
  • Credit Suisse fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $186M.
  • Credit Suisse's ten largest holdings make up 20% of its $110B portfolio in Q1 2019.
  • Credit Suisse opened 439 new positions and closed 327 in Q1 2019.
  • Credit Suisse's portfolio value rose 14% quarter-over-quarter to $110B.

Based on Credit Suisse's 13F filing for Q1 2019, filed 14 May 2019.